<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0040">
 <label>40.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Taylor</surname>
   <given-names>JG</given-names>
  </string-name>, 
  <string-name>
   <surname>Zipfel</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Ramey</surname>
   <given-names>K</given-names>
  </string-name>, et al. 
  <article-title>Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): a component of Vosevi
   <sup>®</sup>
  </article-title>. 
  <source>
   <italic toggle="yes">Bioorg Med Chem Lett</italic>
  </source>. 
  <year>2019</year>;
  <volume>29</volume>:
  <fpage>2428</fpage>–
  <lpage>2436</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2019.03.037</pub-id>
  <pub-id pub-id-type="pmid">31133531</pub-id>
 </mixed-citation>
</ref>
